FDA Finalizes Home-Use Device Guidance, Consistent With Draft
This article was originally published in The Gray Sheet
Executive Summary
The agency issued guidelines on designing devices for the home, sticking with most of its 2012 draft, despite complaints from industry.
You may also be interested in...
Scope Of FDA’s Home-Use Device Draft Guidance Is Too Broad, Industry Says
Many of the comments on FDA's draft guidance on design considerations for devices intended for home use voiced concerns about the expansive scope of the document.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.